GPT and Skin rash: There was no significant statistical difference observed regarding occurrence of adverse outcome such as skin rash, hemoglobin count, aspartate aminotransferase count, and alanine aminotransferase levels in participants with NVP plasma levels > 6000 ng/mL when compared to participants with lower NVP plasma levels (Table 2).